Skip to main content
. Author manuscript; available in PMC: 2009 Aug 15.
Published in final edited form as: Biochem Pharmacol. 2008 Jun 17;76(4):482–494. doi: 10.1016/j.bcp.2008.05.032

Figure 1.

Figure 1

Chemical structure of the synthetic A3AR-selective agonist, CF502, used in this study. The bicyclic ring system (fused cyclopentane and cyclopropane rings) in place of the ribose moiety maintains a nucleoside conformation that is preferred in the A3AR binding site (Tchilibon, et al., 2005).